Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Statistics

Total Valuation

RNTX has a market cap or net worth of $28.43 million. The enterprise value is $23.45 million.

Market Cap	28.43M
Enterprise Value	23.45M

Important Dates

The last earnings date was Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

RNTX has 23.31 million shares outstanding. The number of shares has increased by 71.80% in one year.

Current Share Class	23.31M
Shares Outstanding	23.31M
Shares Change (YoY)	+71.80%
Shares Change (QoQ)	+8.99%
Owned by Insiders (%)	1.04%
Owned by Institutions (%)	18.66%
Float	19.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	25.88
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.90

Current Ratio	0.90
Quick Ratio	0.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -83.28% and return on invested capital (ROIC) is -21.01%.

Return on Equity (ROE)	-83.28%
Return on Assets (ROA)	-18.81%
Return on Invested Capital (ROIC)	-21.01%
Return on Capital Employed (ROCE)	-49.56%
Revenue Per Employee	n/a
Profits Per Employee	-$5.35M
Employee Count	11
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.54% in the last 52 weeks. The beta is 1.28, so RNTX's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	-58.54%
50-Day Moving Average	1.31
200-Day Moving Average	1.61
Relative Strength Index (RSI)	40.12
Average Volume (20 Days)	2,606,103

Short Selling Information

The latest short interest is 63,312, so 0.27% of the outstanding shares have been sold short.

Short Interest	63,312
Short Previous Month	26,079
Short % of Shares Out	0.27%
Short % of Float	0.32%
Short Ratio (days to cover)	0.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-23.77M
Pretax Income	-60.43M
Net Income	-58.89M
EBITDA	-23.77M
EBIT	-23.77M
Earnings Per Share (EPS)	-$2.50

Balance Sheet

The company has $4.05 million in cash and n/a in debt, giving a net cash position of $4.05 million or $0.17 per share.

Cash & Cash Equivalents	4.05M
Total Debt	n/a
Net Cash	4.05M
Net Cash Per Share	$0.17
Equity (Book Value)	46.19M
Book Value Per Share	0.05
Working Capital	-570,000

Cash Flow

Operating Cash Flow	-20.95M
Capital Expenditures	n/a
Free Cash Flow	-20.95M
FCF Per Share	-$0.90

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-71.80%
Shareholder Yield	-71.80%
Earnings Yield	-214.13%
FCF Yield	-76.19%

Analyst Forecast

The average price target for RNTX is $10.00, which is 719.67% higher than the current price. The consensus rating is "Buy".

Price Target	$10.00
Price Target Difference	719.67%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 11, 2022
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1